Loading
Life sciences · Observational Study
ClinicalTrials.gov · October 1, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07531966). This is a study registration, not published results. Lead sponsor: University of Aarhus. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 60 participants (ESTIMATED). Conditions: Kidney Transplant Recipient, Kidney Transplant; Complications, Transplant Renal Artery Stenosis, Renovascular Disease, Renal Transplant Graft Failure, Renovascular Hypertension, Heart Failure. Interventions: DIAGNOSTIC_TEST: Catheter-based angiography; DIAGNOSTIC_TEST: Measurement of translesional pressure gradients; DIAGNOSTIC_TEST: Intravascular ultrasound (IVUS); PROCEDURE: Percutaneous transluminal angioplasty (PTA). Primary outcome measures: Change in measured glomerular filtration rate (mGFR). , Baseline and 3 months post-PTA.. Brief summary: * To determine the incidence of arterial inflow problems and venous outflow problems as causes of impaired renal function and/or treatment-resistant hypertension after kidney transplantation, when all kidney-transplant recipients in Denmark are evaluated according to uniform, well-defined clinical criteria. * To investigate the efficacy and safety of catheter-based balloon treatment (percutaneous transluminal angioplasty, PTA) for these vascular complications, of which transplant renal artery stenosis is by far the most common. * To assess whether novel imaging and functional diagnostic methods can predict treatment response.